189 related articles for article (PubMed ID: 34134902)
1. Second invasive breast cancers in patients treated with breast-conserving therapy.
Wang J; Tang H; Yin K; Li X; Xie X; Hughes KS
Eur J Surg Oncol; 2021 Oct; 47(10):2492-2498. PubMed ID: 34134902
[TBL] [Abstract][Full Text] [Related]
2. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
[TBL] [Abstract][Full Text] [Related]
3. True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy.
Panet-Raymond V; Truong PT; McDonald RE; Alexander C; Ross L; Ryhorchuk A; Watson PH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):409-17. PubMed ID: 21288654
[TBL] [Abstract][Full Text] [Related]
4. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis.
Nishimura S; Takahashi K; Akiyama F; Oguchi M; Tada K; Makita M; Iwase T; Yoshimoto M; Yamashita T; Sakamoto G; Kasumi F
Breast Cancer; 2005; 12(2):112-7. PubMed ID: 15858441
[TBL] [Abstract][Full Text] [Related]
5. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
6. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
Laird J; Lok B; Siu C; Cahlon O; Khan AJ; McCormick B; Powell SN; Cody H; Wen HY; Ho A; Braunstein LZ
Ann Surg Oncol; 2018 Jan; 25(1):154-163. PubMed ID: 29094250
[TBL] [Abstract][Full Text] [Related]
7. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.
Yi M; Buchholz TA; Meric-Bernstam F; Bedrosian I; Hwang RF; Ross MI; Kuerer HM; Luo S; Gonzalez-Angulo AM; Buzdar AU; Symmans WF; Feig BW; Lucci A; Huang EH; Hunt KK
Ann Surg; 2011 Mar; 253(3):572-9. PubMed ID: 21209588
[TBL] [Abstract][Full Text] [Related]
8. Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.
Hattangadi-Gluth JA; Wo JY; Nguyen PL; Abi Raad RF; Sreedhara M; Niemierko A; Freer PE; Georgian-Smith D; Bellon JR; Wong JS; Smith BL; Harris JR; Taghian AG
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1185-91. PubMed ID: 21601377
[TBL] [Abstract][Full Text] [Related]
9. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up.
Kunkler IH; Kerr GR; Thomas JS; Jack WJ; Bartlett JM; Pedersen HC; Cameron DA; Dixon JM; Chetty U;
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):829-38. PubMed ID: 22197227
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
11. True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment.
Yoshida T; Takei H; Kurosumi M; Ninomiya J; Ishikawa Y; Hayashi Y; Tozuka K; Oba H; Kawanowa K; Inoue K; Tabei T
Breast J; 2010; 16(2):127-33. PubMed ID: 20030655
[TBL] [Abstract][Full Text] [Related]
12. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence.
Su Y; Guo R; Xue J; Chi Y; Chi W; Wang J; Yang B; Wu J
Oncologist; 2019 Sep; 24(9):e818-e827. PubMed ID: 30842240
[TBL] [Abstract][Full Text] [Related]
13. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
14. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.
Smith TE; Lee D; Turner BC; Carter D; Haffty BG
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1281-9. PubMed ID: 11121624
[TBL] [Abstract][Full Text] [Related]
15. Influence of XRCC4 expression by breast cancer cells on ipsilateral recurrence after breast-conserving therapy.
Kitagawa M; Someya M; Hasegawa T; Mikami T; Asaishi K; Hasegawa T; Matsumoto Y; Kutomi G; Takemasa I; Sakata KI
Strahlenther Onkol; 2019 Jul; 195(7):648-658. PubMed ID: 30997540
[TBL] [Abstract][Full Text] [Related]
16. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
Huang E; Buchholz TA; Meric F; Krishnamurthy S; Mirza NQ; Ames FC; Feig BW; Kuerer HM; Ross MI; Singletary SE; McNeese MD; Strom EA; Hunt KK
Cancer; 2002 Nov; 95(10):2059-67. PubMed ID: 12412158
[TBL] [Abstract][Full Text] [Related]
17. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.
Dalberg K; Mattsson A; Sandelin K; Rutqvist LE
Breast Cancer Res Treat; 1998 May; 49(1):69-78. PubMed ID: 9694613
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
[No Abstract] [Full Text] [Related]
19. Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.
Gosset M; Hamy AS; Mallon P; Delomenie M; Mouttet D; Pierga JY; Lae M; Fourquet A; Rouzier R; Reyal F; Feron JG
PLoS One; 2016; 11(8):e0159888. PubMed ID: 27494111
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence risk after previous salvage mastectomy.
Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
